Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PAAD | rs835957 | chr10:3588319 | G/A | 0.00016 | 177 | 20.47 | 13.13 | 16.07 | KM Plot |
PAAD | rs848193 | chr1:16285267 | C/G | 2.11E-6 | 176 | 15.57 | 14.57 | 3.43 | KM Plot |
PAAD | rs848201 | chr1:16245362 | G/A | 1.68E-6 | 178 | 15.67 | 12.88 | 3.43 | KM Plot |
PAAD | rs848202 | chr1:16247681 | G/A | 1.68E-6 | 178 | 15.67 | 12.88 | 3.43 | KM Plot |
PAAD | rs848203 | chr1:16250666 | A/G | 1.67E-6 | 178 | 15.57 | 14.57 | 3.43 | KM Plot |
PAAD | rs848204 | chr1:16252670 | C/A | 1.68E-6 | 178 | 15.67 | 12.88 | 3.43 | KM Plot |
PAAD | rs848206 | chr1:16252996 | A/G | 1.45E-6 | 178 | 15.62 | 14 | 3.43 | KM Plot |
PAAD | rs848208 | chr1:16255644 | C/T | 1.68E-6 | 178 | 15.67 | 12.88 | 3.43 | KM Plot |
PAAD | rs848211 | chr1:16260916 | C/T | 1.96E-6 | 177 | 15.67 | 11.77 | 3.43 | KM Plot |
PAAD | rs848295 | chr1:16306012 | G/C | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs848298 | chr1:16314900 | T/C | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs848299 | chr1:16314957 | T/A | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs848300 | chr1:16315146 | C/T | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs848301 | chr1:16315262 | C/G | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs848307 | chr1:16319232 | A/G | 1.97E-6 | 176 | 3.43 | 15.53 | 15.5 | KM Plot |